|Bid||33.03 x 200|
|Ask||33.17 x 400|
|Day's Range||32.69 - 33.00|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||27.78|
|Dividend & Yield||1.28 (3.87%)|
|1y Target Est||N/A|
United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal ...
Philosopher Blaise Pascal never faced proof he was wrong to believe in God. AstraZeneca's Pascal Soriot has discovered his faith in the Mystic cancer drug trial really was misplaced. A failure of a key ...
For the past few months, Gilead Sciences, Inc. (NASDAQ:GILD) could not fulfill the technical upside promise. Last night, GILD report earnings and the stock is spiking toward $76. Click to Enlarge Coming into the earnings, sentiment had also shifted in favor of better days to come from GILD stock, and I am one who likes to trade with the market sentiment.